000 01365 a2200433 4500
005 20250517012456.0
264 0 _c20150910
008 201509s 0 0 eng d
022 _a1757-6199
024 7 _a10.4155/bio.14.274
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKhan, Masood U
245 0 0 _aRecommendations for adaptation and validation of commercial kits for biomarker quantification in drug development.
_h[electronic resource]
260 _bBioanalysis
_c2015
300 _a229-42 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomarkers
_xanalysis
650 0 4 _aCalibration
650 0 4 _aDrug Discovery
_xmethods
650 0 4 _aGovernment Regulation
650 0 4 _aGuidelines as Topic
650 0 4 _aHumans
650 0 4 _aImmunoassay
_xstandards
650 0 4 _aReagent Kits, Diagnostic
700 1 _aBowsher, Ronald R
700 1 _aCameron, Mark
700 1 _aDevanarayan, Viswanath
700 1 _aKeller, Steve
700 1 _aKing, Lindsay
700 1 _aLee, Jean
700 1 _aMorimoto, Alyssa
700 1 _aRhyne, Paul
700 1 _aStephen, Laurie
700 1 _aWu, Yuling
700 1 _aWyant, Timothy
700 1 _aLachno, D Richard
773 0 _tBioanalysis
_gvol. 7
_gno. 2
_gp. 229-42
856 4 0 _uhttps://doi.org/10.4155/bio.14.274
_zAvailable from publisher's website
999 _c24533060
_d24533060